|Articles|October 27, 2021

Aktana secures new machine learning automation technology

Acquisition reportedly increases AI accessibility across life sciences organizations

Aktana, a software company specializing in intelligent customer engagement for the life sciences, has acquired Ople.AI’s machine learning automation technology. According to Aktana, the deal puts artificial intelligence (AI) access into the hands of non-data scientists, which makes it simpler for companies of all sizes to utilize AI. With Ople.AI’s technology, Aktana notes, its branded modular solution—which features its software-as-a-service (SaaS) platform—can potentially help speed up AI adoption across commercial decision-makers.

The announcement comes at a time when many companies are applying AI in order to prioritize the various obstacles they face in today’s digital-first landscape.

By streamlining the building and use of machine learning with back-end automation, users, including those without a technical background, will have the capability of creating and managing their own models on Aktana’s platform. The software company will also be adding to its collection of pre-built machine learning models.


Related to this article

Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS). | © Tada Images - stock.adobe.com 521699065
In this week’s Pharma Pulse, the FDA launches a program that lets companies share its approval packages with foreign regulators, UPS agrees to acquire Australia and New Zealand health care courier Smartways Logistics and Cognizant introduces an AI-enabled patient hub offering.